The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of hydroxychloroquine plus binimetinib in patients with metastatic pancreatic cancer (the HOPE trial).
 
Rishi Surana
No Relationships to Disclose
 
J. Jack Lee
Honoraria - AstraZeneca
 
Brandon George Smaglo
Speakers' Bureau - Sirtex Medical; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Marker Therapeutics
 
Dan Zhao
No Relationships to Disclose
 
Michael Sangmin Lee
Consulting or Advisory Role - Pfizer
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Exelixis (Inst); Genentech/Roche (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Robert A. Wolff
Honoraria - Modern Medicine
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Michael J. Overman
Consulting or Advisory Role - 3D Medicines; Array BioPharma; Bristol-Myers Squibb; Gritstone Bio; Janssen; Janssen; MedImmune; Merck; Novartis; Pfizer; Pfizer; Promega; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Jason Willis
Honoraria - Cor2Ed
 
Channing J. Der
Honoraria - Bayer; Deciphera; Jazz Pharmaceuticals; Lilly; Mirati Therapeutics
Consulting or Advisory Role - Axon Advisors; Bayer; Cowen; Deciphera; Jazz Pharmaceuticals; Lilly; Mirati Therapeutics; PiperJaffrey; SmartAnalyst; SVB Leerink; Third Bridge
Research Funding - Deciphera (Inst); Mirati Therapeutics (Inst)
Travel, Accommodations, Expenses - Deciphera; Lilly; Mirati Therapeutics
 
Shubham Pant
Honoraria - 4D Pharma
Consulting or Advisory Role - Ipsen; Xencor; Zymeworks
Research Funding - 4D Pharma (Inst); Arcus Biosciences (Inst); ArQule (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Five Prime Therapeutics (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); Mirati Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Novartis (Inst); Onco Response (Inst); Purple Biotech (Inst); RedHill Biopharma (Inst); Rgenix (Inst); Sanofi/Aventis (Inst); Xencor (Inst)